1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

This listing may be outdated. Verify details at the official source before applying.

Find similar grants

ActivePharmaceutical Companies (via RxHope) · 2026

RxHope Patient Assistance Program

Quick Facts

Agency: Pharmaceutical Companies (via RxHope)
Funding: Low-cost or free medications
Deadline: Check Source
Status: Active
Eligibility: Low-income patients with a chronic illness. A physician must apply on behalf of the patient.

About This Grant

RxHope works directly with pharmaceutical companies to help low-income patients obtain low-cost medications. A physician must complete the application on the patient's behalf.

View Original RFP

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Eligibility Requirements

Low-income patients with a chronic illness. A physician must apply on behalf of the patient.

Frequently Asked Questions

Who can apply for RxHope Patient Assistance Program?

According to the current listing, eligibility includes: Low-income patients with a chronic illness. A physician must apply on behalf of the patient. Confirm the full requirements in the official notice before applying.

Who funds RxHope Patient Assistance Program?

RxHope Patient Assistance Program is funded by Pharmaceutical Companies (via RxHope). Verify program details on the funder's official page before applying.

How do I apply for RxHope Patient Assistance Program?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Competitive Intelligence

Past winners and funding trends for this program

Full analysis

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Pharmaceutical Companies (via RxHope) Grant Writing Tips

Commerce Rescinded $200M in Tech Hubs Awards, Then Re-Awarded $169M to Six Regions — Here Is Who Won, Who Lost, and What It Signals for 2027

On July 20, 2026, the EDA announced it intends to invest $169 million across six Regional Technology and Innovation Hubs — quantum, nuclear, critical minerals, biosecure manufacturing, pharmaceuticals, and forest bioproducts — after the Trump administration rescinded the Biden-era Phase 2 awards and reran the competition. Only two of the original winners survived. Here is the full breakdown of the six hubs, why four prior awardees were dropped, and what the re-award teaches regional coalitions about competing for the next round.

Read article